Trials / Conditions / RRMM

RRMM

3 registered clinical trials studyying RRMM.

Status	Trial	Sponsor	Phase
Terminated	A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients NCT04412707	Oncopeptides AB	Phase 2
Unknown	Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Ce NCT03778346	The Sixth Affiliated Hospital of Wenzhou Medical University	Phase 1
Terminated	Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475 NCT02684617	Merck Sharp & Dohme LLC	Phase 1